These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32166380)

  • 1. Infection at diagnosis-a unique challenge in acute myeloid leukemia treatment in developing world.
    Pandian J; Raghavan V; Manuprasad A; Shenoy PK; Nair CK
    Support Care Cancer; 2020 Nov; 28(11):5449-5454. PubMed ID: 32166380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on combination of homoharringtonine, Ara-C and idarubicin induction for treatment of newly diagnosed acute myeloid leukemia patients].
    Qin TJ; Xu ZF; Fang LW; Zhang HL; Zhang Y; Wang JZ; Pan LJ; Hu NB; Xiao ZJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1277-82. PubMed ID: 22040988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center.
    Jain H; Rengaraj K; Sharma V; Bonda A; Chanana R; Thorat J; Ronghe A; Biswas S; Nayak L; Tembhare P; Subramnian P; Shetty D; Patkar N; Bagal B; Sengar M
    JCO Glob Oncol; 2020 Nov; 6():1684-1695. PubMed ID: 33156719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
    Ciftciler R; Demiroglu H; Haznedaroglu IC; Sayınalp N; Aksu S; Ozcebe O; Goker H; Aydın MS; Buyukasık Y
    Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):729-734. PubMed ID: 31540855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy.
    Zhu HH; Jiang H; Jiang B; Lu J; Jiang Q; Bao L; Zhang XH; Qin YZ; Huang XJ
    Leuk Lymphoma; 2013 Nov; 54(11):2452-7. PubMed ID: 23432721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
    PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
    Lim MJ; Agha A; Im A; Raptis A; Hou JZ; Boyiadzis M; Sehgal AR; Redner RL; Dorritie K; Marks SS; Agha ME; Lim SH
    Hematol Oncol; 2018 Apr; 36(2):495-497. PubMed ID: 28664979
    [No Abstract]   [Full Text] [Related]  

  • 9. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
    Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
    Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome.
    Bow EJ; Kilpatrick MG; Scott BA; Clinch JJ; Cheang MS
    Cancer; 1994 Jul; 74(1):52-60. PubMed ID: 8004583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
    Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
    Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fluid overload and infection on respiratory adverse event development during induction therapy for childhood acute myeloid leukemia.
    Miller LH; Keller F; Mertens A; Klein M; Allen K; Castellino S; Woods WG
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27975. PubMed ID: 31502412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively.
    Gao S; Li Z; Fu JH; Hu XH; Xu Y; Jin ZM; Tang XW; Han Y; Chen SN; Sun AN; Wu DP; Qiu HY
    Asian Pac J Cancer Prev; 2015; 16(15):6627-32. PubMed ID: 26434886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Patients With de novo Acute Myeloid Leukemia Resistant to Initial Induction Chemotherapy.
    Wu S; Yang S; Zhu L; Wang Y; Zhang Y; Zhou J; Li D
    Am J Med Sci; 2016 May; 351(5):473-9. PubMed ID: 27140705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.
    Mendes FR; da Silva WF; da Costa Bandeira de Melo R; Silveira DRA; Velloso EDRP; Rocha V; Rego EM
    Ann Hematol; 2022 Jan; 101(1):147-154. PubMed ID: 34676435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.
    Konuma T; Harada K; Yamasaki S; Mizuno S; Uchida N; Takahashi S; Onizuka M; Nakamae H; Hidaka M; Fukuda T; Ohashi K; Kohno A; Matsushita A; Kanamori H; Ashida T; Kanda J; Atsuta Y; Yano S;
    Am J Hematol; 2019 Jan; 94(1):103-110. PubMed ID: 30370944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAG regimen improves survival in adult patients with hypocellular acute myeloid leukemia.
    Hu X; Fu W; Wang L; Gao L; Lü S; Xi H; Qiu H; Chen L; Chen J; Ni X; Xu X; Zhang W; Yang J; Wang J; Song X
    Oncotarget; 2016 Jan; 7(3):3623-34. PubMed ID: 26497216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Efficacy of Decitabine-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia].
    Li GH; Chen RA; Ji YR; Qin WW; Chen Y; Wang WQ; Liu C; Zhou NC; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):743-749. PubMed ID: 29950214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.
    Harada K; Doki N; Hagino T; Miyawaki S; Ohtake S; Kiyoi H; Miyazaki Y; Fujita H; Usui N; Okumura H; Miyamura K; Nakaseko C; Fujieda A; Nagai T; Yamane T; Sakamaki H; Ohnishi K; Naoe T; Ohno R; Ohashi K
    Ann Hematol; 2018 Jan; 97(1):73-81. PubMed ID: 29196987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.